UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.407

Sortiert nach

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological features and impact of adjuvant chemotherapy on the long‐term survival of patients with multiple gastric cancers: a propensity score matching analysis

Cancer communications (London, England), 2019-02, Vol.39 (1), p.1-11

2019

Link zum Volltext

Verfügbarkeit prüfen

Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer

Cancer communications (London, England), 2019-11, Vol.39 (1), p.76-76, Article 76

Zhang, Xiangyu

2019

Link zum Volltext

Verfügbarkeit prüfen

Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis

Cancer communications (London, England), 2019-09, Vol.39 (1), p.1-12

2019

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10

2019

Link zum Volltext

Verfügbarkeit prüfen

National trend of gastric cancer mortality in China (2003–2015): a population‐based study

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-5

2019

Link zum Volltext

Verfügbarkeit prüfen

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy

Cancer communications (London, England), 2019-10, Vol.39 (1), p.1-11

2019

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-8

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification of genetic alterations associated with primary resistance to EGFR‐TKIs in advanced non‐small‐cell lung cancer patients with EGFR sensitive mutations

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-15

2019

Link zum Volltext

Verfügbarkeit prüfen

Implications of evidence-based understanding of benefits and risks for cancer prevention strategy

Hong Kong medical journal = Xianggang yi xue za zhi, 2019-10, Vol.25 (5), p.346-348

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer

Cancer communications (London, England), 2019-11, Vol.39 (1), p.78-78, Article 78

2019

Link zum Volltext

Verfügbarkeit prüfen

CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-13

2019

Link zum Volltext

Verfügbarkeit prüfen

The Role of Plasma CDO1 Methylation in the Early Diagnosis of Lung Cancer

Zhongguo fei ai za zhi, 2020-05, Vol.23 (5), p.314-320

2020

Link zum Volltext

Verfügbarkeit prüfen

Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening

Hong Kong medical journal = Xianggang yi xue za zhi, 2022-04, Vol.28 (2), p.161-168

2022

Link zum Volltext

Verfügbarkeit prüfen

Modelling the probability of erroneous negative lymph node staging in patients with colon cancer

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer statistics in China, 2016

Zhōnghuá zhŏngliú zázhì, 2023-03, Vol.45 (3), p.212

2023

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier Integrity in Lung Cancer Patients with Leptomeningeal Metastasis

Zhongguo fei ai za zhi, 2021-08, Vol.24 (8), p.567-576

2021

Link zum Volltext

Verfügbarkeit prüfen

DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation

Zhongguo fei ai za zhi, 2021-07, Vol.24 (7), p.453-460

2021

Link zum Volltext

Verfügbarkeit prüfen

Status and Rationality of Opioid Use in Lung Cancer Patients: A Single Center Retrospective Study

Zhongguo fei ai za zhi, 2020-04, Vol.23 (4), p.233-238

2020

Link zum Volltext

Verfügbarkeit prüfen

Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway

Journal of Zhejiang University. B. Science, 2023-03, Vol.24 (3), p.207-220

2023

Link zum Volltext

Verfügbarkeit prüfen

Irinotecan plus S‐1 versus S‐1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open‐labeled phase 3 trial

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-10

2019

Link zum Volltext

Verfügbarkeit prüfen

Analysis and prediction of thyroid cancer morbidity and mortality trends in China

Zhōnghuá liúxíngbìng zázhì, 2023-06, Vol.44 (6), p.917

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical applications of high-intensity focused ultrasound

Hong Kong medical journal = Xianggang yi xue za zhi, 2016-08, Vol.22 (4), p.382-392

2016

Link zum Volltext

Verfügbarkeit prüfen

A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study

Cancer communications (London, England), 2019-11, Vol.39 (1), p.80-80, Article 80

2019

Link zum Volltext

Verfügbarkeit prüfen

Research status and prospect of artificial intelligence technology in the diagnosis of urinary system tumors

Sheng wu yi xue gong cheng xue za zhi, 2021-12, Vol.38 (6), p.1219

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.407

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Journals

SpracheDänisch

SpracheChinesisch

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(791)
Mit Volltextzugriff
(872)

Publikationsform

Artikel
(1.407)

Sprache

Englisch
(217)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy

Clinicopathological features and impact of adjuvant chemotherapy on the long‐term survival of patients with multiple gastric cancers: a propensity score matching analysis

Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer

Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2‐positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial

National trend of gastric cancer mortality in China (2003–2015): a population‐based study

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy

The efficacy and safety of modified FOLFIRINOX as first‐line chemotherapy for Chinese patients with metastatic pancreatic cancer

Identification of genetic alterations associated with primary resistance to EGFR‐TKIs in advanced non‐small‐cell lung cancer patients with EGFR sensitive mutations

Implications of evidence-based understanding of benefits and risks for cancer prevention strategy

Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer

CMAB009 plus irinotecan versus irinotecan‐only as second‐line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild‐type metastatic colorectal cancer patients: promising findings from a prospective, open‐label, randomized, phase III trial

The Role of Plasma CDO1 Methylation in the Early Diagnosis of Lung Cancer

Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening

Modelling the probability of erroneous negative lymph node staging in patients with colon cancer

Cancer statistics in China, 2016

Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier Integrity in Lung Cancer Patients with Leptomeningeal Metastasis

DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation

Status and Rationality of Opioid Use in Lung Cancer Patients: A Single Center Retrospective Study

Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway

Irinotecan plus S‐1 versus S‐1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open‐labeled phase 3 trial

Analysis and prediction of thyroid cancer morbidity and mortality trends in China

Clinical applications of high-intensity focused ultrasound

A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study

Research status and prospect of artificial intelligence technology in the diagnosis of urinary system tumors

Aktive Filter

Suchergebnisse filtern